Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome.

Ho PM, Maddox TM, Wang L, Fihn SD, Jesse RL, Peterson ED, Rumsfeld JS.

JAMA. 2009 Mar 4;301(9):937-44. doi: 10.1001/jama.2009.261.

PMID:
19258584
2.

Cardiovascular outcomes associated with concomitant use of clopidogrel and proton pump inhibitors in patients with acute coronary syndrome in Taiwan.

Lin CF, Shen LJ, Wu FL, Bai CH, Gau CS.

Br J Clin Pharmacol. 2012 Nov;74(5):824-34. doi: 10.1111/j.1365-2125.2012.04250.x.

3.

One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.

Ortolani P, Marino M, Marzocchi A, De Palma R, Branzi A.

J Cardiovasc Med (Hagerstown). 2012 Dec;13(12):783-9. doi: 10.2459/JCM.0b013e3283416b6b.

PMID:
21252697
4.

Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel.

Wu CY, Chan FK, Wu MS, Kuo KN, Wang CB, Tsao CR, Lin JT.

Gastroenterology. 2010 Oct;139(4):1165-71. doi: 10.1053/j.gastro.2010.06.067. Epub 2010 Jun 30.

PMID:
20600012
5.

Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.

Hsiao FY, Mullins CD, Wen YW, Huang WF, Chen PF, Tsai YW.

Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1043-9. doi: 10.1002/pds.2202. Epub 2011 Aug 8.

PMID:
21823195
6.

Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.

Bhurke SM, Martin BC, Li C, Franks AM, Bursac Z, Said Q.

Pharmacotherapy. 2012 Sep;32(9):809-18. doi: 10.1002/j.1875-9114.2012.01112.x. Epub 2012 Jun 28.

7.

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.

Nicolau JC, Bhatt DL, Roe MT, Lokhnygina Y, Neely B, Corbalán R, Leiva-Pons JL, Martinez F, Goodman SG, Winters KJ, Verheugt FW, Armstrong PW, White HD, Fox KA, Prabhakaran D, Ohman EM; TRILOGY ACS investigators.

Am Heart J. 2015 Oct;170(4):683-694.e3. doi: 10.1016/j.ahj.2015.05.017. Epub 2015 Jun 11.

PMID:
26386792
8.

Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study.

Ray WA, Murray KT, Griffin MR, Chung CP, Smalley WE, Hall K, Daugherty JR, Kaltenbach LA, Stein CM.

Ann Intern Med. 2010 Mar 16;152(6):337-45. doi: 10.7326/0003-4819-152-6-201003160-00003.

9.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD.

Lancet. 2009 Sep 19;374(9694):989-97. doi: 10.1016/S0140-6736(09)61525-7. Epub 2009 Aug 31. Review.

PMID:
19726078
10.

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.

Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.

Clin Ther. 2009 Sep;31(9):2038-47. doi: 10.1016/j.clinthera.2009.09.005.

PMID:
19843493
11.

Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome.

Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, Jesse RA, Rumsfeld JS.

JAMA. 2008 Feb 6;299(5):532-9. doi: 10.1001/jama.299.5.532. Erratum in: JAMA. 2008 May 28;299(20):2390.

PMID:
18252883
12.

Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.

Stockl KM, Le L, Zakharyan A, Harada AS, Solow BK, Addiego JE, Ramsey S.

Arch Intern Med. 2010 Apr 26;170(8):704-10. doi: 10.1001/archinternmed.2010.34.

PMID:
20421557
13.

Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study.

Weisz G, Smilowitz NR, Kirtane AJ, Rinaldi MJ, Parvataneni R, Xu K, Stuckey TD, Maehara A, Witzenbichler B, Neumann FJ, Metzger DC, Henry TD, Cox DA, Duffy PL, Brodie BR, Mazzaferri EL Jr, Mehran R, Stone GW.

Circ Cardiovasc Interv. 2015 Oct;8(10). pii: e001952. doi: 10.1161/CIRCINTERVENTIONS.114.001952.

14.

Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.

Banerjee S, Weideman RA, Weideman MW, Little BB, Kelly KC, Gunter JT, Tortorice KL, Shank M, Cryer B, Reilly RF, Rao SV, Kastrati A, de Lemos JA, Brilakis ES, Bhatt DL.

Am J Cardiol. 2011 Mar 15;107(6):871-8. doi: 10.1016/j.amjcard.2010.10.073. Epub 2011 Jan 19.

PMID:
21247527
15.

[Effect of drug interaction between clopidogrel and omeprazole in hospital readmision of patients by a recurrent acute coronary syndrome: a case-control study].

Amariles P, Holguín H, Angulo NY, Betancourth PM, Ceballos M.

Aten Primaria. 2014 Oct;46(8):426-32. doi: 10.1016/j.aprim.2013.11.007. Epub 2014 Feb 26. Spanish.

16.

Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review.

Sherwood MW, Melloni C, Jones WS, Washam JB, Hasselblad V, Dolor RJ.

J Am Heart Assoc. 2015 Oct 29;4(11). pii: e002245. doi: 10.1161/JAHA.115.002245. Review.

17.

Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patients.

Mahabaleshwarkar RK, Yang Y, Datar MV, Bentley JP, Strum MW, Banahan BF, Null KD.

Curr Med Res Opin. 2013 Apr;29(4):315-23. doi: 10.1185/03007995.2013.772051. Epub 2013 Feb 11.

PMID:
23362935
18.

Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome.

Rassen JA, Choudhry NK, Avorn J, Schneeweiss S.

Circulation. 2009 Dec 8;120(23):2322-9. doi: 10.1161/CIRCULATIONAHA.109.873497. Epub 2009 Nov 23.

19.

Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial.

Goodman SG, Clare R, Pieper KS, Nicolau JC, Storey RF, Cantor WJ, Mahaffey KW, Angiolillo DJ, Husted S, Cannon CP, James SK, Kilhamn J, Steg PG, Harrington RA, Wallentin L; Platelet Inhibition and Patient Outcomes Trial Investigators.

Circulation. 2012 Feb 28;125(8):978-86. doi: 10.1161/CIRCULATIONAHA.111.032912. Epub 2012 Jan 18.

20.

Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).

Ojeifo O, Wiviott SD, Antman EM, Murphy SA, Udell JA, Bates ER, Mega JL, Sabatine MS, O'Donoghue ML.

JACC Cardiovasc Interv. 2013 Dec;6(12):1275-81. doi: 10.1016/j.jcin.2013.06.014. Epub 2013 Nov 13.

Supplemental Content

Support Center